pyrazines has been researched along with Thyroid Carcinoma, Anaplastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, KY; Fagin, JA; Ghossein, R; Knauf, JA; Luckett, KA; Socci, ND; Voza, F | 1 |
Ahn, BC; Baek, SH; Gangadaran, P; Hong, CM; Jeong, SY; Kalimuthu, SK; Lee, HW; Lee, J; Lee, SW; Li, XJ; Min, OJ; Rajendran, RL; Zhu, L | 1 |
Altmann, A; Askoxylakis, V; Eisenhut, M; Haberkorn, U; Jesenofsky, R; Markert, A; Schöning, T | 1 |
3 other study(ies) available for pyrazines and Thyroid Carcinoma, Anaplastic
Article | Year |
---|---|
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Cell Line, Tumor; Coumarins; Crizotinib; Disease Models, Animal; Drug Resistance, Neoplasm; Genes, p53; Humans; Indoles; MAP Kinase Signaling System; Mice; Mice, Transgenic; Mutation, Missense; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyrazines; Sulfonamides; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Triazoles | 2018 |
New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Extracellular Vesicles; Female; Genes, Reporter; Humans; Imidazoles; Luciferases, Renilla; Luminescent Agents; Mice; Mice, Nude; Optical Imaging; Pyrazines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Mice, Inbred BALB C; Organ Specificity; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |